Although elevated levels of c-Myc and c-Met have been reported in HCC and gastric cancer patients, it is not yet certain whether these proteins are responsible for AFP-promoted progression of liver and gastric cancers [10, 18]. The gene discussed is MYC; the disease is hepatocellular carcinoma.